Filed April 22, 2026

Serial No. 99780347

Examining Attorney JEFFREY S. MOLINOFF

Class Chemical preparations for pharmaceutical purposes, namely, for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Anti-inflammatory agents; Pharmaceutical anti-allergic preparations and substances; Antidepressants; Anti-epiletic pharmaceutical preparations; Flour for pharmaceutical purposes; Medicinal preparations for the mouth and as sprays; Chemical preparations for pharmaceutical purposes, namely, for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Active pharmaceutical ingredients for chemical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Active pharmaceutical ingredients for chemical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Neuroleptic agents being pharmaceutical preparations for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Neuroleptic agents being pharmaceutical preparations for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Medicinal agents being chemical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Medicinal agents being chemical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Nervines being chemical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Nervines being chemical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Chemical preparations for medical purposes, namely, for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Chemical preparations for medical purposes, namely, for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Medicinal drinks; Chemico-pharmaceutical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Chemico-pharmaceutical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Pharmaceutical drugs for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Pharmaceutical drugs for the treatment of or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Pharmaceutical preparations for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Pharmaceutical preparations for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Lozenges for pharmaceutical purposes, namely, for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Lozenges for pharmaceutical purposes, namely, for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Chemical reagents for medical purposes; Bronchodilating preparations; Pharmaceutical preparations for treating asthma; Inhalants for the treatment of respiratory conditions; Analgesics; Anti-inflammatories; Anti-inflammatory and analgesic agents; Muscle relaxants; Biological preparations for use in cell cultures for medical purposes; Antidiabetic preparations; Medical preparations for slimming purposes; Slimming pills; Appetite suppressants for medical purposes; Appetite suppressant pills; Pre-filled syringes for medical purposes, namely, for the treatment or prevention of neurodegenerative or neurodevelopmental diseases and disorders; Pre-filled syringes for medical purposes, namely, for the treatment or prevention of multiple system atrophy, Parkinson's disease, Alzheimer's disease, or schizophrenia; Food supplements, namely, antioxidant pills; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark